| Result |
Filter:
|
|||||||||||||||||||||||
| ID | SEQUENCE | LENGTH | VIRUS | INHIBITION/ IC50 |
UNIT | TARGET | ASSAY | PMID | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVP1056 | RWMVWRHWFHRLRLPYNPGKNKQNQQWP | 28 | DENV 2 | 8±1 | μM | Virus entry | Focus reduction assay | |||||||||||||||||
| AVP1057 | RQMRAWGQDYQHGGMGYSC | 19 | DENV 2 | 36±6 | μM | Virus entry | Focus reduction assay | |||||||||||||||||
| AVP1058 | FWFTLIKTQAKQPARYRRFC | 20 | DENV 2 | 7±4 | μM | Virus entry | Focus reduction assay | |||||||||||||||||
| AVP1199 | CGYKLC | 6 | DENV 2 | 16.7 | μM | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1200 | CGYGLC | 7 | DENV 2 | 15.1 | Ki (μM) | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1201 | CGYGLC | 6 | DENV 2 | >100 | Ki (μM) | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1202 | CGYKGC | 6 | DENV 2 | 12 | Ki (μM) | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1203 | CGYKRC | 6 | DENV 2 | 5 | Ki (μM) | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1204 | CGKRRC | 6 | DENV 2 | 3.5 | Ki (μM) | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1205 | CGKRKLC | 7 | DENV 2 | 6.7 | μM | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1206 | CGKRKSC | 9 | DENV 2 | 3.3 | μM | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1207 | AGKRKSG | 8 | DENV 2 | 16.7 | μM | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1208 | CAGKRKSG | 12 | DENV 2 | 6.7 | μM | Replication | Flouroscence spectrtophotometery | |||||||||||||||||
| AVP1235 | MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY | 33 | DENV 2 | 2to5 | μM | Virucidal | Focus reduction assay | |||||||||||||||||
| AVP1252 | GWVKPAKLDG | 10 | DENV 2 | 0 | % | Virus entry | Plaque assay | |||||||||||||||||
| AVP1253 | PWLKPGDLDL | 10 | DENV 2 | 40.6 | % | Virus entry | Plaque assay | |||||||||||||||||
| AVP1254 | IGVRPGKLDL | 10 | DENV 2 | 0 | % | Virus entry | Plaque assay | |||||||||||||||||
| AVP1255 | AGVKDGKLDF | 10 | DENV 2 | 84.6 | % | Virus entry | Plaque assay | |||||||||||||||||
| AVP1579 | FWFTLIKTQAKQPARYRRFC | 20 | DENV 2 | 3 | μM | Antibody dependent enhancement effect | ADE inhibition assay | |||||||||||||||||
| AVP1580 | MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY | 33 | DENV 2 | 6 | μM | Antibody dependent enhancement effect | ADE inhibition assay | |||||||||||||||||
| AVP1760 | AWDFGSLGGVFTSIGKALHQVFGAIYGAA | 29 | DENV 2 | 0.3 | μM(IC90) | Virus entry | Plaque assay | |||||||||||||||||
| AVP1792 | AWDFGSVGGVLNSLGKMVHQIFGSAYTAL | 29 | DENV 2 | 2 | μM(IC90) | Virus entry | Plaque assay | |||||||||||||||||
| AVP1793 | AWDFGSIGGVFTSVGKLVHQVFGTAYGVL | 29 | DENV 2 | 2 | μM(IC90) | Virus entry | Plaque assay | |||||||||||||||||
| AVP1796 | AWDFGSIGGVFTSVGKLVHQVFGTAYGVL | 29 | DENV 2 | 6 | μM(IC90) | Virus entry | Plaque assay | |||||||||||||||||
| AVP1811 | GICRCICGRGICRCICGRIGGRVPGVGVPGVGHHHHHH | 38 | DENV 2 | 21.4±1.6 | μM | Replication | Plaque assay | |||||||||||||||||
| AVP1821 | RGGRLCYCRRRFCVCVGR | 18 | DENV 2 | 11.7 | μM | Replication | RT PCR | |||||||||||||||||
|
||||||||||||||||||||||||
 |
 |